Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Exercise/Conversion of 25,000 AMLX shares, $44.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Exercise/Conversion | 25,000 | $44.0K |
| Jun 8, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 24,372 | n/a |
| May 26, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 3,800 | $51.3K |
| Dec 24, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 8,100 | $100.8K |
| Jun 9, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 25,000 | n/a |
| Sep 9, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 50,000 | $106.6K |
| Jun 7, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 25,000 | n/a |
| Dec 19, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 4,000 | $59.9K |
| Jun 12, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 3,908 | n/a |
| Mar 21, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 1,000 | $32.0K |